Sintx Technologies (SINT) Return on Capital Employed (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,440.00 |
| Dec 31, 2025 | 13,837.00 |
| Sep 30, 2025 | -930.00 |
| Jun 30, 2025 | -55.00 |
| Mar 31, 2025 | 672.00 |
| Dec 31, 2024 | -3,367.00 |
| Sep 30, 2024 | -4,271.00 |
| Jun 30, 2024 | 1,371.00 |
| Mar 31, 2024 | 155.00 |
| Dec 31, 2023 | -667.00 |
| Sep 30, 2023 | -2,502.00 |
| Jun 30, 2023 | 1,039.00 |
| Mar 31, 2023 | 7,461.00 |
| Dec 31, 2022 | -7,594.00 |
| Sep 30, 2022 | -1,113.00 |
| Jun 30, 2022 | -1,259.00 |
| Mar 31, 2022 | -871.00 |
| Dec 31, 2021 | -588.00 |
| Sep 30, 2021 | -513.00 |
| Jun 30, 2021 | -452.00 |
| Mar 31, 2021 | -633.00 |
| Dec 31, 2020 | 164.00 |
| Sep 30, 2020 | 1,217.00 |
| Jun 30, 2020 | 2,442.00 |
| Mar 31, 2020 | 1,655.00 |
| Dec 31, 2019 | -13,738.00 |
| Sep 30, 2019 | 6,413.00 |
| Jun 30, 2019 | 555.00 |
| Mar 31, 2019 | 68.00 |
| Dec 31, 2018 | 5,303.00 |
| Sep 30, 2018 | -2,463.00 |
| Jun 30, 2018 | 761.00 |
| Mar 31, 2018 | -1,927.00 |
| Mar 31, 2017 | 570.00 |
| Dec 31, 2016 | 2,420.00 |
| Dec 31, 2015 | 1,609.00 |
| Sep 30, 2015 | -165.00 |
| Jun 30, 2015 | 1,974.00 |
| Mar 31, 2015 | 101.00 |
| Dec 31, 2014 | 1,287.00 |
| Sep 30, 2014 | -2,370.00 |
| Jun 30, 2014 | -2,965.00 |